#obesity-treatment
#obesity-treatment

3 weeks ago

Miscellaneous

Eli Lilly's 3-step strategy to dominate the $95 billion obesity market

fromFuturism

NYC startup

Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.

fromArs Technica

11 months ago

Medicine

Eli Lilly raises price of Zepbound while trumpeting discount on starter vials

3 weeks ago

Miscellaneous

Eli Lilly's 3-step strategy to dominate the $95 billion obesity market

fromFuturism

NYC startup

Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.

fromArs Technica

11 months ago

Medicine

Eli Lilly raises price of Zepbound while trumpeting discount on starter vials

Public health

Weight loss jabs study begins after reports of pancreas issues

7 months ago

Medicine

Which Weight-Loss Drug Is Better: Wegovy or Zepbound?

fromwww.bbc.com

Public health

Weight loss jabs study begins after reports of pancreas issues

fromwww.independent.co.uk

7 months ago

Medicine

Which Weight-Loss Drug Is Better: Wegovy or Zepbound?

more#weight-loss-drugs

UK news

Poll: Should weight loss drugs be widely available on the NHS?

The Independent emphasizes the importance of accessible journalism and the new NHS weight loss treatment.

#weight-loss

Alternative medicine

Weight loss jabs may achieve less drastic results outside trials, study suggests

fromScienceDaily

Alternative medicine

Beyond Ozempic: New weight loss drug rivals surgery

fromWIRED

Alternative medicine

A New Obesity Pill May Burn Fat Without Suppressing Appetite

fromwww.bbc.com

Alternative medicine

Weight-loss drugs tested in head-to-head trial

Mental health

Weight-loss jabs may be good for mental health, research shows

Alternative medicine

Weight loss jabs may achieve less drastic results outside trials, study suggests

fromScienceDaily

Alternative medicine

Beyond Ozempic: New weight loss drug rivals surgery

fromWIRED

Alternative medicine

A New Obesity Pill May Burn Fat Without Suppressing Appetite

fromwww.bbc.com

Alternative medicine

Weight-loss drugs tested in head-to-head trial

Mental health

Weight-loss jabs may be good for mental health, research shows

more#weight-loss

fromNature

How to keep weight off after obesity drugs

Sheree's struggle emphasizes the increasing reliance on non-traditional methods for weight management amidst the challenges presented by GLP-1 therapies.

Alternative medicine

fromScienceDaily

Weight loss linked to nerve cells in the brain

This suggests that these nerve cells control the beneficial effects of semaglutide. We have therefore identified a specific group of nerve cells that is necessary for the effects that semaglutide has on weight and appetite, but which does not appear to contribute to any significant extent to side effects such as nausea.

Alternative medicine

#pharmaceuticals

fromwww.mercurynews.com

Wearables

Zepbound trims more belly fat than Wegovy, study shows

fromwww.npr.org

4 months ago

Healthcare

Consumers can buy Zepbound direct from the drugmaker if they'll pay out of pocket

fromwww.mercurynews.com

Zepbound trims more belly fat than Wegovy, study shows

Eli Lilly's Zepbound outperformed Novo Nordisk's Wegovy in a recent study, showing superior weight loss and waist circumference reduction.

Healthcare

fromwww.npr.org

4 months ago

Consumers can buy Zepbound direct from the drugmaker if they'll pay out of pocket

Eli Lilly's Zepbound reaches 100,000 direct buyers monthly, showing a shift towards online drug sales despite insurance coverage limitations.

more#pharmaceuticals

#ozempic

fromenglish.elpais.com

Alternative medicine

The Ozempic universe expands: These drugs also treat fatty liver disease

from24/7 Wall St.

Wearables

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Alternative medicine

fromenglish.elpais.com

The Ozempic universe expands: These drugs also treat fatty liver disease

Ozempic drugs show promise in treating fatty liver disease, halting or reversing its progression, and may provide broader therapeutic effects beyond weight loss.

from24/7 Wall St.

Wearables

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)

more#ozempic

Pfizer Ends Development of Its Obesity Pill

Pfizer's decision to halt danuglipron development underscores the risks and complexities involved in creating new obesity treatments, particularly after significant financial investment and testing phases.

Wearables

#medicare

Medicine

Medicare Will Not Cover GLP-1 Drugs for Weight Loss

Medicare and Medicaid will not cover weight-loss drugs for obesity treatment, affecting millions.

Medicine

Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs

Trump administration rejects Biden's proposal on obesity drug coverage for Medicare and Medicaid.

Medicine

Medicare Will Not Cover GLP-1 Drugs for Weight Loss

Medicare and Medicaid will not cover weight-loss drugs for obesity treatment, affecting millions.

Medicine

Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs

Trump administration rejects Biden's proposal on obesity drug coverage for Medicare and Medicaid.

Trump scraps Biden's plan to cover Wegovy and Zepbound through Medicare

Trump administration's decision excludes expensive obesity treatments from Medicare coverage.

Alternative medicine

fromwww.npr.org

4 months ago

Patients scramble as cheaper obesity drug alternatives disappear

Obesity treatments are transforming patients' relationship with food but compounding alternatives to popular drugs face restrictions.

FDA's declaration ends availability of compounded tirzepatide, causing distress among patients who rely on it.

Healthcare

fromwww.mercurynews.com

5 months ago

Patients struggle with lack of consistent coverage for popular weight-loss drugs

Access to obesity treatments is hindered by inconsistent insurance coverage and high costs, making it difficult for many to maintain weight loss.

US news

fromBoston.com

5 months ago

Could obesity drugs help with alcohol cravings? New study suggests potential

GLP-1 receptor agonists show potential in reducing alcohol cravings but safety for non-obese individuals remains uncertain.

fromIrish Independent

7 months ago

Mounjaro, the 'King Kong' of weight loss jabs, will be available in Ireland early next year

Mounjaro, a medicine used with diet and exercise, helps adults with type 2 diabetes not adequately controlled and can assist in weight loss.

Medicine

Exercise